Leopold Sellner

19PUBLICATIONS
63CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Apr 17, 2026
A Phase 2, Open-Label, Multicenter Study of the Safety and Efficacy of TAK-007 in Adult Patients with Relapsed/Refractory B-cell Non-Hodgkin Lymphoma.

|Jan 30, 2025
Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.

Jae H Park, M Lia Palomba, Karlo Perica

|Feb 25, 2022
HDAC Inhibition for Optimized Cellular Immunotherapy of NY-ESO-1-Positive Soft Tissue Sarcoma.

Wenjie Gong, Lei Wang, Maria-Luisa Schubert

|Jan 11, 2022
Intracellular Amplifiers of Reactive Oxygen Species Affecting Mitochondria as Radiosensitizers.

Hong-Gui Xu, Viktor Reshetnikov, Marit Wondrak

|Oct 08, 2021
Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.

Leopold Sellner, Johannes Schetelig, Linda Koster

|Feb 02, 2021
EOMES and IL-10 regulate antitumor activity of T regulatory type 1 CD4+ T cells in chronic lymphocytic leukemia.

Philipp M Roessner, Laura Llaó Cid, Ekaterina Lupar

Pageof 4

Frequent Collaborators

5 joint publications

Michael Schmitt

4 joint publications

Sophia Stock

2 joint publications

W Huber

2 joint publications

Pavel Jindra